Notably, P4HA2 has been reported to be a prognostic biomarker in cervical cancer, which was increased expression in cervical cancer tissues compared with the adjacent normal tissues, and related to poor prognosis [52, 53]. This evidence concerns the gene P4HA2 and cervical carcinoma.